News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
310,831 Results
Type
Article (13952)
Company Profile (28)
Press Release (296851)
Multimedia
Podcasts (20)
Webinars (7)
Section
Business (101889)
Career Advice (666)
Deals (13020)
Drug Delivery (38)
Drug Development (41116)
Employer Resources (45)
FDA (7137)
Job Trends (7163)
News (159654)
Policy (10506)
Tag
2024 BioForest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1285)
Accelerated approval (2)
Adcomms (5)
Allergies (51)
Alliances (16054)
ALS (60)
Alzheimer's disease (809)
Antibody-drug conjugate (ADC) (75)
Approvals (7212)
Artificial intelligence (146)
Autoimmune disease (19)
Automation (11)
Bankruptcy (70)
Best Places to Work (6680)
BIOSECURE Act (3)
Biosimilars (36)
Biotechnology (26)
Bladder cancer (58)
Brain cancer (11)
Breast cancer (197)
Cancer (1434)
Cardiovascular disease (100)
Career advice (546)
Career pathing (21)
CAR-T (83)
Cell therapy (254)
Cervical cancer (10)
Clinical research (34178)
Collaboration (515)
Compensation (192)
Complete response letters (2)
COVID-19 (1500)
CRISPR (28)
C-suite (166)
Cystic fibrosis (78)
Data (1482)
Decentralized trials (2)
Denatured (6)
Depression (25)
Diabetes (118)
Diagnostics (2976)
Digital health (8)
Diversity (3)
Diversity, equity & inclusion (18)
Drug discovery (59)
Drug pricing (18)
Drug shortages (5)
Duchenne muscular dystrophy (58)
Earnings (53255)
Editorial (20)
Employer branding (2)
Employer resources (45)
Events (70988)
Executive appointments (557)
FDA (7890)
Featured Employer (12)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (541)
Gene editing (66)
Generative AI (10)
Gene therapy (168)
GLP-1 (263)
Government (1967)
Grass and pollen (3)
Guidances (38)
Healthcare (9680)
Huntington's disease (17)
IgA nephropathy (14)
Immunology and inflammation (52)
Indications (22)
Infectious disease (1571)
Inflammatory bowel disease (78)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (48)
Interviews (118)
IPO (7050)
IRA (8)
Job creations (901)
Job search strategy (468)
Kidney cancer (6)
Labor market (14)
Layoffs (137)
Leadership (11)
Legal (1580)
Liver cancer (34)
Lung cancer (206)
Lymphoma (98)
Machine learning (3)
Management (22)
Manufacturing (144)
MASH (27)
Medical device (6148)
Medtech (6150)
Mergers & acquisitions (6321)
Metabolic disorders (295)
Multiple sclerosis (51)
NASH (6)
Neurodegenerative disease (45)
Neuropsychiatric disorders (11)
Neuroscience (1138)
NextGen: Class of 2025 (2963)
Non-profit (3200)
Northern California (1720)
Now hiring (3)
Obesity (153)
Opinion (116)
Ovarian cancer (51)
Pain (39)
Pancreatic cancer (44)
Parkinson's disease (103)
Partnered (11)
Patents (101)
Patient recruitment (66)
Peanut (32)
People (30082)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (10636)
Phase II (15064)
Phase III (11814)
Pipeline (753)
Policy (35)
Postmarket research (1100)
Preclinical (3855)
Press Release (25)
Prostate cancer (83)
Psychedelics (7)
Radiopharmaceuticals (134)
Rare diseases (231)
Real estate (1745)
Recruiting (13)
Regulatory (8020)
Reports (13)
Research institute (1281)
Resumes & cover letters (101)
Rett syndrome (4)
RNA editing (3)
RSV (33)
Schizophrenia (47)
Series A (101)
Series B (63)
Service/supplier (2)
Sickle cell disease (36)
Southern California (1441)
Special edition (6)
Spinal muscular atrophy (102)
Sponsored (12)
Startups (1651)
State (1)
Stomach cancer (4)
Supply chain (35)
Tariffs (12)
The Weekly (14)
United States (14475)
Vaccines (507)
Venture capitalists (24)
Weight loss (73)
Women's health (11)
Worklife (8)
Date
Today (32)
Last 7 days (494)
Last 30 days (1558)
Last 365 days (19980)
2025 (6549)
2024 (20041)
2023 (21646)
2022 (25947)
2021 (27909)
2020 (26236)
2019 (22368)
2018 (16921)
2017 (14678)
2016 (14007)
2015 (16875)
2014 (12625)
2013 (9455)
2012 (10085)
2011 (11009)
2010 (9419)
Location
Africa (283)
Alabama (26)
Alaska (5)
Arizona (83)
Arkansas (5)
Asia (13572)
Australia (2400)
California (3852)
Canada (990)
China (237)
Colorado (162)
Connecticut (216)
Delaware (112)
Europe (36649)
Florida (475)
Georgia (131)
Idaho (16)
Illinois (320)
India (12)
Indiana (208)
Iowa (7)
Japan (116)
Kansas (38)
Kentucky (13)
Louisiana (2)
Maine (22)
Maryland (593)
Massachusetts (3195)
Michigan (128)
Minnesota (252)
Mississippi (2)
Missouri (60)
Montana (11)
Nebraska (12)
Nevada (35)
New Hampshire (34)
New Jersey (1103)
New Mexico (23)
New York (1060)
North Carolina (557)
North Dakota (6)
Northern California (1720)
Ohio (124)
Oklahoma (5)
Oregon (13)
Pennsylvania (783)
Puerto Rico (4)
Rhode Island (15)
South America (405)
South Carolina (7)
South Dakota (1)
Southern California (1441)
Tennessee (64)
Texas (549)
Utah (90)
Virginia (77)
Washington D.C. (23)
Washington State (379)
West Virginia (2)
Wisconsin (44)
310,831 Results for "henry m jackson foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jackson Pharmacy Professionals Unveils Brand Refresh and New Identity as “Jackson PharmacyPros”
December 11, 2024
·
2 min read
Press Releases
The Prostate Cancer Foundation Appoints Phillip Koo, M.D., as Chief Medical Officer
April 8, 2025
·
3 min read
Business
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic Antibody Discovery
The Jackson Laboratory, an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and derisk the development of vital new therapies.
May 10, 2024
·
3 min read
Press Releases
CTNNB1 Foundation awarded €1M as Slovenia backs nonprofit gene therapy - a first step toward equitable cures for rare diseases
March 31, 2025
·
1 min read
Business
The Jackson Laboratory and LG AI Research partner to pioneer biomedical advancements
The Jackson Laboratory and LG AI Research signed a partnership agreement creating an alliance between JAX’s longstanding expertise in biomedical research and data analysis and LG’s AI research and product development prowess.
March 11, 2024
·
4 min read
Business
Henry Schein to Webcast First Quarter 2024 Conference Call on Tuesday, May 7, 2024 at 10:00 A.M. ET
Henry Schein, Inc. announced that it will release its first quarter 2024 financial results before the stock market opens on Tuesday, May 7, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time.
April 11, 2024
·
6 min read
Business
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
Calidi Biotherapeutics, Inc. today announced the appointment of Andrew Jackson as Chief Financial Officer.
October 30, 2023
·
3 min read
Press Releases
Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology
January 14, 2025
·
4 min read
Press Releases
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
February 25, 2025
·
20 min read
Pharm Country
Henry Schein to Present at Investor Conferences in May 2024
Henry Schein, Inc. announced today that the Company will present at the following investor conferences in May.
April 29, 2024
·
2 min read
1 of 31,084
Next
